Today's announcement provided more evidence to support a bright forecast for BOT's future.
However, after witnessing the recent fiasco with RAP (for long term holders), this has me speculating what the future roadmap could look like. I for one profited well from a short-term hold of RAP, but long-term holders whom bought high were sold out to Big Pharma, which for some cases resulted in a significant loss.
What are the chances of BOT selling out to Big Pharma, versus BOT actually making it to production/distribution on it's own accord?
Keen to hear other investor's thoughts, albeit acknowledge any response is pure speculation at this stage.
Chris.
What's the chances? Future sell out to big pharma, or go our own way?
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
0.015(4.76%) |
Mkt cap ! $597.3M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.5¢ | 32.3¢ | $1.265M | 3.862M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 129446 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 131308 | 2 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |